Zydus Wellness Sees 2.2% Growth Despite Seasonal Setbacks in Q1 FY26

reported 2.2% YoY revenue growth in Q1 FY26, reaching ₹8,577 Mn despite early monsoon disruptions affecting Nycil & Glucon D. Excluding seasonal brands, strong double-digit growth was achieved. EBITDA was flat (+0.2%), while PAT fell 13.4% due to non-cash amortization. Gross margins dropped 73 bps, though most core brands expanded margins. E-comm share rose to 14.5%, and Rite Bite Max Protein beat expectations.